Anosognosia predicts default mode network hypometabolism and clinical progression to dementia

Objective To identify the pathophysiologic mechanisms and clinical significance of anosognosia for cognitive decline in mild cognitive impairment. Methods We stratified 468 patients with amnestic mild cognitive impairment into intact and impaired awareness groups, determined by the discrepancy between the patient and the informant score on the Everyday Cognition questionnaire. Voxel-based linear regression models evaluated the associations between self-awareness status and baseline β-amyloid load, measured by [18F]florbetapir, and the relationships between awareness status and regional brain glucose metabolism measured by [18F]fluorodeoxyglucose at baseline and at 24-month follow-up. Multivariate logistic regression tested the association of awareness status with conversion from amnestic mild cognitive impairment to dementia. Results We found that participants with impaired awareness had lower [18F]fluorodeoxyglucose uptake and increased [18F]florbetapir uptake in the posterior cingulate cortex at baseline. In addition, impaired awareness in mild cognitive impairment predicted [18F]fluorodeoxyglucose hypometabolism in the posterior cingulate cortex, left basal forebrain, bilateral medial temporal lobes, and right lateral temporal lobe over 24 months. Furthermore, participants with impaired awareness had a nearly 3-fold increase in likelihood of conversion to dementia within a 2-year time frame. Conclusions Our results suggest that anosognosia is linked to Alzheimer disease pathophysiology in vulnerable structures, and predicts subsequent hypometabolism in the default mode network, accompanied by an increased risk of progression to dementia. This highlights the importance of assessing awareness of cognitive decline in the clinical evaluation and management of individuals with amnestic mild cognitive impairment.

[1]  N. Foster,et al.  Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease , 1997, Annals of neurology.

[2]  Lisa Geraci,et al.  How Well Do the ADAS-cog and its Subscales Measure Cognitive Dysfunction in Alzheimer’s Disease? , 2009, Dementia and Geriatric Cognitive Disorders.

[3]  K. Worsley,et al.  Unified univariate and multivariate random field theory , 2004, NeuroImage.

[4]  Malaz Boustani,et al.  Alzheimer's Association recommendations for operationalizing the detection of cognitive impairment during the Medicare Annual Wellness Visit in a primary care setting , 2013, Alzheimer's & Dementia.

[5]  R. Penn,et al.  Stiff‐man syndrome treated with intrathecal baclofen , 1993, Neurology.

[6]  R. Buckner,et al.  Functional-Anatomic Fractionation of the Brain's Default Network , 2010, Neuron.

[7]  R. Robinson,et al.  A diagnostic formulation for anosognosia in Alzheimer’s disease , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[8]  R. Petersen,et al.  Mild cognitive impairment , 2006, The Lancet.

[9]  Keith A. Johnson,et al.  Memory self-awareness in the preclinical and prodromal stages of Alzheimer’s disease , 2017, Neuropsychologia.

[10]  J. Hodges,et al.  Focal posterior cingulate atrophy in incipient Alzheimer's disease , 2010, Neurobiology of Aging.

[11]  P. Boyle,et al.  Temporal course and pathologic basis of unawareness of memory loss in dementia , 2015, Neurology.

[12]  D. Schacter,et al.  The Brain's Default Network , 2008, Annals of the New York Academy of Sciences.

[13]  V. Buckles,et al.  Accuracy of Collateral Source Reports in Very Mild to Mild Dementia of the Alzheimer Type , 2003, Journal of the American Geriatrics Society.

[14]  S. Starkstein Anosognosia in Alzheimer's disease: Diagnosis, frequency, mechanism and clinical correlates , 2014, Cortex.

[15]  Min Su Kang,et al.  Amyloid-β and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer's disease , 2016, Molecular Psychiatry.

[16]  Christopher G. Davey,et al.  Mapping the self in the brain's default mode network , 2016, NeuroImage.

[17]  Karl Herholz,et al.  Neural correlates of anosognosia for cognitive impairment in Alzheimer's disease , 2006, Human brain mapping.

[18]  R. Gräsbeck The evolution of the reference value concept , 2004, Clinical chemistry and laboratory medicine.

[19]  Kathleen Baynes,et al.  The measurement of everyday cognition (ECog): scale development and psychometric properties. , 2008, Neuropsychology.

[20]  Alana T. Wong,et al.  Remembering the past and imagining the future: Common and distinct neural substrates during event construction and elaboration , 2007, Neuropsychologia.

[21]  F. Piras,et al.  Self-awareness in Mild Cognitive Impairment: Quantitative evidence from systematic review and meta-analysis , 2016, Neuroscience & Biobehavioral Reviews.

[22]  Sterling C. Johnson,et al.  Anosognosia in mild cognitive impairment: Relationship to activation of cortical midline structures involved in self-appraisal , 2007, Journal of the International Neuropsychological Society.

[23]  S. Leurgans,et al.  Loss of basal forebrain P75NTR immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease , 2002, The Journal of comparative neurology.

[24]  Francis Eustache,et al.  The Default Mode Network in Healthy Aging and Alzheimer's Disease , 2011, International journal of Alzheimer's disease.

[25]  H. Braak,et al.  Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.

[26]  F. Piras,et al.  Neuroanatomical correlates of awareness of illness in patients with amnestic mild cognitive impairment who will or will not convert to Alzheimer's disease , 2014, Cortex.

[27]  Anthony F Jorm Assessment of cognitive impairment and dementia using informant reports , 1996 .

[28]  W. Snow,et al.  The prediction of Alzheimer disease. The role of patient and informant perceptions of cognitive deficits. , 1996, Archives of neurology.

[29]  Brigitte Landeau,et al.  Anosognosia in Alzheimer disease: Disconnection between memory and self‐related brain networks , 2015, Annals of neurology.

[30]  J. Hodges,et al.  Limbic hypometabolism in Alzheimer's disease and mild cognitive impairment , 2003, Annals of neurology.

[31]  J. Coyle,et al.  Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. , 1982, Science.

[32]  Georg Northoff,et al.  Self-referential processing in our brain—A meta-analysis of imaging studies on the self , 2006, NeuroImage.

[33]  Keith A. Johnson,et al.  A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers , 2016, Neurology.

[34]  Benjamin J. Shannon,et al.  Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory , 2005, The Journal of Neuroscience.

[35]  S. Gauthier,et al.  Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease , 2017, Neurology.